Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility. Am Fam Physician. 2015;91(5):308–14.
De Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730–8.
Penzias A, Azziz R, Bendikson K, Cedars M, Falcone T, Hansen K, et al. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021;116(5):1255–65.
Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Human Reprod Sci. 2020;13(4):261.
Heshmati J, Sepidarkish M, Morvaridzadeh M, Farsi F, Tripathi N, Razavi M, et al. The effect of cinnamon supplementation on glycemic control in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Food Biochem. 2021;45(1):e13543.
Article CAS PubMed Google Scholar
Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;1(1):CD010290.
Anderson K, Nisenblat V, Norman R. Lifestyle factors in people seeking infertility treatment–a review. Aust N Z J Obstet Gynaecol. 2010;50(1):8–20.
Anwar S, Anwar A. Infertility: a review on causes, treatment and management. Womens Health Gynecol. 2016;5:2–5.
Schatten H, Sun Q-Y, Prather R. The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility. Reprod Biol Endocrinol. 2014;12:1–11.
Messinis IE. Ovulation induction: a mini review. Hum Reprod. 2005;20(10):2688–97.
Article CAS PubMed Google Scholar
Glanville EJ, Wilkinson J, Sadler L, Wong TY, Acharya S, Aziz N, et al. A randomized trial of endometrial scratching in women with PCOS undergoing ovulation induction cycles. Reprod BioMed Online. 2022;44(2):316–23.
Kousta E, White D, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 1997;3(4):359–65.
Article CAS PubMed Google Scholar
Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993;59(3):532–8.
Article CAS PubMed Google Scholar
Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2010;2010(1):CD000057.
Ajdary M, Keyhanfar F, Aflatoonian R, Amani A, Amjadi F, Zandieh Z, et al. Design and evaluation of a novel nanodrug delivery system for reducing the side effects of clomiphene citrate on endometrium. DARU J Pharmaceut Sci. 2020;28(2):423–32.
Davar R, Javedani M, Fallahzadeh MH. Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iran J Reprod Med. 2011;9(1):31.
CAS PubMed PubMed Central Google Scholar
Choi S-H, Shapiro H, Robinson GE, Irvine J, Neuman J, Rosen B, et al. Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin. J Psychosom Obstet Gynecol. 2005;26(2):93–100.
Talebi Tamajani Z, Mohammadi SD, Gorji M, Alimoradi Z. Comparison of the efficacy of Letrozole versus Clomiphene Citrate among Iranian infertile females: a systematic review and meta-analysis. Iran J Obstetr Gynecol Infertil. 2019;22(7):89–102.
Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, et al. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(3):301–12.
Article CAS PubMed Google Scholar
Ahmadi S, Seraj M, Chiani M, Hosseini S, Bazzazan S, Akbarzadeh I, et al. In vitro development of controlled-release nanoniosomes for improved delivery and anticancer activity of letrozole for breast cancer treatment. Int J Nanomedicine. 2022:6233–55.
Malloch L, Rhoton-Vlasak A. An assessment of current clinical attitudes toward letrozole use in reproductive endocrinology practices. Fertil Steril. 2013;100(6):1740–4.
Article CAS PubMed Google Scholar
Hosseini-Najarkolaei A, Moini A, Kashani L, Farid Mojtahedi M, Hosseini-Najarkolaee E, Salehi E. The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial. Reprod Biol Endocrinol. 2020;18(1):1–7.
Ramezanzadeh F, Nasiri R, Sarafraz Yazdi M, Baghrei M. A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Arch Gynecol Obstet. 2011;284(4):1029–34.
Article CAS PubMed Google Scholar
Wallace KL, Johnson V, Sopelak V, Hines R. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril. 2011;96(4):1051–6.
Article CAS PubMed Google Scholar
Al-Obaidi MT, Ali ZH, AL-Saadi WI, AL-Wasiti EA, Al-Aubaidy H. Impact of letrozole versus clomiphene citrate on endometrial receptivity in Iraqi women with polycystic ovarian syndrome. J Clin Pharm Ther. 2019;44(4):618–22.
Article CAS PubMed Google Scholar
Al-Shoraky Mohamed S, El-Din Hussien H, Ahmed El-Desouky E-S. Letrozole versus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Al-Azhar Med J. 2020;49(1):209–18.
Bansal S, Goyal M, Sharma C, Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial. Int J Gynaecol Obstet. 2021;152(3):345–50.
Article CAS PubMed Google Scholar
Dehbashi S, Dehbashi S, Kazerooni T, Robati M, Alborzi S, Parsanezhad ME, et al. Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iran J Med Sci. 2009;34(1):23–8.
Kamath MS, George K. Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate. Reprod Biol Endocrinol. 2011;9(1):1–4.
Estrada A, Boyce AM, Brillante BA, Guthrie LC, Gafni RI, Collins MT. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune–Albright syndrome. Eur J Endocrinol. 2016;175(5):477–83.
Article CAS PubMed PubMed Central Google Scholar
Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119–29.
Article PubMed PubMed Central Google Scholar
Asgharnia M, Mehrafza M, Raoufi A, Zare Yousefi T, Hosseinzadeh E, Samadnia S, et al. The efficiency of low-dose letrozole plus clomiphene citrate for ovulation induction in intrauterine insemination cycles: a randomized clinical trial. Int J Gynecol Obstet. 2022;159(1):182–7.
Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones. 2021;20(3):449–61.
He D, Jiang F. Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod BioMed Online. 2011;23(1):91–6.
Article CAS PubMed Google Scholar
Roque M, Tostes AC, Valle M, Sampaio M, Geber S. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol. 2015;31(12):917–21.
Article CAS PubMed Google Scholar
Panda SR, Sharmila V, Kalidoss VK, Hota S. A triple-blind, randomized, controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndrome. Int J Gynaecol Obstet. 2023;161(1):63–70.
Article CAS PubMed Google Scholar
Sharif YH. The induction of ovulation in women with polycystic ovarian syndrome via: letrozole vs Clomiphene citrate. Journal of Pharmaceutical Negative Results. 2022;13(1):30–4.
Yland JJ, Chiu Y-H, Rinaudo P, Hsu J, Hernán MA, Hernández-Díaz S. Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction. Hum Reprod. 2022;37(4):793–805.
Article CAS PubMed PubMed Central Google Scholar
Badr FS. Combined letrozole with clomiphene citrate versus letrozole only in induction of ovulation in polycystic ovary syndrome patients (a randomized controlled trial). Egypt J Fertil Steril. 2022;26(3):33–9.
Moher D, Liberati A, Tetzlaff J, Altman DG for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366.
Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–34.
Article CAS PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Comments (0)